What to do if standard therapy for hepatitis C fails
Open Access
- 28 May 2009
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (41)
- https://doi.org/10.3410/m1-41
Abstract
What to do if standard therapy for hepatitis C failsThis publication has 17 references indexed in Scilit:
- Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis CJournal of Viral Hepatitis, 2008
- Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirinJournal of Hepatology, 2008
- Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trialJournal of Hepatology, 2007
- Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis CJournal of Hepatology, 2005
- Peginterferon Alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment1,2,3Gastroenterology, 2004
- Diagnosis, management, and treatment of hepatitis CJournal of Hepatology, 2004
- Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359–362]Journal of Hepatology, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- Hepatitis C--global prevalence (update).1999
- Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinomaJournal of Hepatology, 1999